High-risk bifascicular / trifascicular block
Advanced conduction disease · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Combined conduction block (e.g. RBBB with fascicular block, +/- first-degree AV block) carrying risk of progression to complete heart block, especially if symptomatic.
Red flags
- Syncope or presyncope
- Alternating bundle branch block
- Progression to complete block
- Concurrent MI
Assessment
Differential diagnosis
- Isolated bundle branch block
- Complete heart block
- Hyperkalaemia
- Drug effect
- Cardiac sarcoid/amyloid
Investigations
- 12-lead ECG and telemetry
- Electrolytes including potassium
- Troponin to exclude ischaemia
- Echocardiography
Management
- Attach continuous cardiac monitoring
- Assess for syncope, ischaemia and reversible causes
- Stop AV nodal blocking drugs if implicated
- Have transcutaneous pacing available for symptomatic bradycardia
- Correct electrolytes and treat ischaemia
- Refer for pacing assessment/EP study
Drugs & doses
Atropine (anticholinergic) - 500 mcg IV for symptomatic bradycardia (limited efficacy infranodal)
Isoprenaline/adrenaline infusion (chronotrope) - bridge if unstable
Avoid additional AV nodal blockers
Disposition
Admit with telemetry for pacing assessment.
Complications & pitfalls
- Complete heart block
- Asystole
- Syncopal injury
Exam pearls
- Atropine is often ineffective for infranodal block
- Syncope with bifascicular block warrants pacing evaluation
- Alternating BBB is a strong pacing indication
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.